{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-037235","form_type":"8-K","ticker":"ARDT","cik":"0001756655","company_name":"Ardent Health, Inc.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.422496+00:00","generated_at":"2026-05-31T09:22:51.396602+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ardent Health Q2 revenue $1.47B, adj. EBITDA $122M (+20%); issues FY24 guidance","bullets":["Q2 revenue $1.47B (+7.5% YoY); net income attributable $43M ($0.34/share).","Adjusted EBITDA $122M, up 20% YoY; adjusted admissions +3.4%.","Full-year 2024 guidance: revenue $5.75-5.90B, Adj. EBITDA $415-435M.","Cash from ops $120M (+$77M YoY); prepaid $100M term loan; net leverage 2.3x.","IPO net proceeds $209M (13.8M shares at $16); pro forma liquidity ~$832M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-037235","json":"https://secwatch.observer/filing/0001628280-24-037235.json","markdown":"https://secwatch.observer/filing/0001628280-24-037235.md","text":"https://secwatch.observer/filing/0001628280-24-037235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/0001628280-24-037235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756655/000162828024037235/ardt-20240814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:22:51.396602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}